Did you discuss cosentyx's affordability?

Did the discussion cover Cosentyx affordability?

I don’t have enough context to confirm whether affordability was discussed. If you share the text you’re referring to (or the key points you want checked), I can verify whether Cosentyx’s cost, pricing, insurance coverage, copays, or patient assistance programs were included.

What “affordability” details are usually expected for Cosentyx?

In most coverage, affordability typically includes things like:
- List price vs. net price (after rebates/discounts)
- Typical copay/coinsurance burden
- Insurance prior authorization or step therapy requirements
- Patient assistance or copay support (if available)
- How affordability compares with similar biologics

If you want, I can help you draft an affordability-focused answer

Paste the passage (or tell me what source constraints you’re working under), and I’ll rewrite or extend it specifically to address affordability for Cosentyx.